Literature DB >> 15784963

Peripheral sensory neurons survive in the absence of alpha- and gamma-synucleins.

Katerina Papachroni1, Natalia Ninkina, Julia Wanless, Anastasios Th Kalofoutis, Nikolai V Gnuchev, Vladimir L Buchman.   

Abstract

Physiological functions of alpha-synuclein, a protein implicated in certain types of neurodegeneration, and two other members of the same family, beta-synuclein and gamma-synuclein, are not clearly understood. It has been suggested that synucleins are involved in intracellular processes associated with survival of neurons and their response to stress, and that changes of synuclein ratio might have deteriorating effects on neurons. In wild-type mice, sensory neurons of the peripheral nervous system express alpha-synuclein and notably high levels of gamma-synuclein, but targeted inactivation of either of these genes has no effect on these neurons. Here we produced double, alpha-synuclein/gamma-synuclein null mutant mice, which develop normally, are fertile, and show no obvious signs of pathology in adulthood. Survival of alpha/gamma-synuclein-deficient peripheral sensory neurons in vivo and in primary tissue culture is indistinguishable from survival of wild-type neurons. The absence of two synucleins does not lead to expression in sensory neurons of the third member of the family, beta-synuclein. Therefore, our results demonstrate that neurons with normally high levels of synuclein(s) can develop and survive normally in the absence of any of these proteins. This suggests that other intraneuronal mechanisms and pathways effectively compensate the loss of synuclein function in null mutant animals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784963     DOI: 10.1385/JMN:25:2:157

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  52 in total

1.  Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein.

Authors:  J E Galvin; K Uryu; V M Lee; J Q Trojanowski
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

2.  Pick's disease: alpha- and beta-synuclein-immunoreactive Pick bodies in the dentate gyrus.

Authors:  Fumiaki Mori; Shintaro Hayashi; Shin-Ichiro Yamagishi; Makoto Yoshimoto; Soroku Yagihashi; Hitoshi Takahashi; Koichi Wakabayashi
Journal:  Acta Neuropathol       Date:  2002-07-02       Impact factor: 17.088

3.  Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease.

Authors:  E Rockenstein; L A Hansen; M Mallory; J Q Trojanowski; D Galasko; E Masliah
Journal:  Brain Res       Date:  2001-09-28       Impact factor: 3.252

4.  alpha-Synuclein shares physical and functional homology with 14-3-3 proteins.

Authors:  N Ostrerova; L Petrucelli; M Farrer; N Mehta; P Choi; J Hardy; B Wolozin
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

Review 5.  Synucleinopathies: clinical and pathological implications.

Authors:  J E Galvin; V M Lee; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-02

Review 6.  Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease.

Authors:  Michael J Volles; Peter T Lansbury
Journal:  Biochemistry       Date:  2003-07-08       Impact factor: 3.162

7.  Identification of two distinct synucleins from human brain.

Authors:  R Jakes; M G Spillantini; M Goedert
Journal:  FEBS Lett       Date:  1994-05-23       Impact factor: 4.124

8.  Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils.

Authors:  Hilal A Lashuel; Benjamin M Petre; Joseph Wall; Martha Simon; Richard J Nowak; Thomas Walz; Peter T Lansbury
Journal:  J Mol Biol       Date:  2002-10-04       Impact factor: 5.469

9.  Neurons expressing the highest levels of gamma-synuclein are unaffected by targeted inactivation of the gene.

Authors:  Natalia Ninkina; Katerina Papachroni; Darren C Robertson; Oliver Schmidt; Liz Delaney; Francis O'Neill; Felipe Court; Arnon Rosenthal; Susan M Fleetwood-Walker; Alun M Davies; Vladimir L Buchman
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 10.  Alpha-synuclein oligomerization: a role for lipids?

Authors:  Kevin Welch; Junying Yuan
Journal:  Trends Neurosci       Date:  2003-10       Impact factor: 13.837

View more
  9 in total

1.  Alpha-synuclein loss in spinal muscular atrophy.

Authors:  Gyula Acsadi; Xingli Li; Kelley J Murphy; Kathryn J Swoboda; Graham C Parker
Journal:  J Mol Neurosci       Date:  2010-07-17       Impact factor: 3.444

2.  Whole genome expression analyses of single- and double-knock-out mice implicate partially overlapping functions of alpha- and gamma-synuclein.

Authors:  Melanie Kuhn; Karina Haebig; Michael Bonin; Natalia Ninkina; Vladimir L Buchman; Sven Poths; Olaf Riess
Journal:  Neurogenetics       Date:  2007-02-22       Impact factor: 2.660

3.  Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease.

Authors:  Liancai Mu; Stanislaw Sobotka; Jingming Chen; Hungxi Su; Ira Sanders; Charles H Adler; Holly A Shill; John N Caviness; Johan E Samanta; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2013-02       Impact factor: 3.685

4.  In vivo electrophysiology of nigral and thalamic neurons in alpha-synuclein-overexpressing mice highlights differences from toxin-based models of parkinsonism.

Authors:  C J Lobb; A K Zaheer; Y Smith; D Jaeger
Journal:  J Neurophysiol       Date:  2013-09-25       Impact factor: 2.714

5.  Autoantibodies to alpha-synuclein in inherited Parkinson's disease.

Authors:  Katerina K Papachroni; Natalia Ninkina; Angeliki Papapanagiotou; Georgios M Hadjigeorgiou; Georgia Xiromerisiou; Alexandros Papadimitriou; Anastasios Kalofoutis; Vladimir L Buchman
Journal:  J Neurochem       Date:  2007-05       Impact factor: 5.372

6.  Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers.

Authors:  Deborah C Mash; Nikhil Adi; Linda Duque; John Pablo; Mahendra Kumar; Frank R Ervin
Journal:  Drug Alcohol Depend       Date:  2007-12-04       Impact factor: 4.492

7.  γ-synuclein is a novel player in the control of body lipid metabolism.

Authors:  Steven Millership; Natalia Ninkina; Justin J Rochford; Vladimir L Buchman
Journal:  Adipocyte       Date:  2013-05-28       Impact factor: 4.534

8.  Synaptic vesicle binding of α-synuclein is modulated by β- and γ-synucleins.

Authors:  Kathryn E Carnazza; Lauren E Komer; Ying Xue Xie; André Pineda; Juan Antonio Briano; Virginia Gao; Yoonmi Na; Trudy Ramlall; Vladimir L Buchman; David Eliezer; Manu Sharma; Jacqueline Burré
Journal:  Cell Rep       Date:  2022-04-12       Impact factor: 9.995

9.  Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice.

Authors:  Abdelmojib Al-Wandi; Natalia Ninkina; Steven Millership; Sally J M Williamson; Paul A Jones; Vladimir L Buchman
Journal:  Neurobiol Aging       Date:  2008-12-20       Impact factor: 4.673

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.